Maurizio Facheris
AbbVie (United States)(US)Bioqual(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Restless Legs Syndrome Research, Botulinum Toxin and Related Neurological Disorders, Child Nutrition and Feeding Issues
Most-Cited Works
- → Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial(2022)177 cited
- → Large-scale replication and heterogeneity in Parkinson disease genetic loci(2012)130 cited
- → Motor and nonmotor heterogeneity of LRRK2‐related and idiopathic Parkinson's disease(2016)125 cited
- → Overexpression of blood microRNAs 103a, 30b, and 29a in l -dopa–treated patients with PD(2015)119 cited
- → A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants(2012)107 cited
- → The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results(2015)103 cited